Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 33 studies | 40% ± 18% | |
pericyte | 18 studies | 36% ± 17% | |
oligodendrocyte precursor cell | 13 studies | 46% ± 21% | |
smooth muscle cell | 12 studies | 38% ± 15% | |
astrocyte | 11 studies | 33% ± 20% | |
connective tissue cell | 8 studies | 43% ± 14% | |
adventitial cell | 5 studies | 44% ± 7% | |
cardiac muscle cell | 4 studies | 19% ± 2% | |
endothelial cell | 4 studies | 31% ± 7% | |
muscle cell | 3 studies | 46% ± 25% | |
chondrocyte | 3 studies | 34% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 8928.86 | 457 / 459 | 97% | 50.34 | 1080 / 1118 |
prostate | 98% | 5670.39 | 240 / 245 | 81% | 15.57 | 407 / 502 |
lung | 90% | 4183.92 | 518 / 578 | 84% | 23.62 | 972 / 1155 |
uterus | 100% | 10754.68 | 170 / 170 | 70% | 36.80 | 323 / 459 |
skin | 89% | 8547.18 | 1611 / 1809 | 75% | 32.93 | 353 / 472 |
thymus | 99% | 8966.58 | 649 / 653 | 59% | 15.87 | 359 / 605 |
ovary | 99% | 4176.26 | 179 / 180 | 42% | 9.20 | 181 / 430 |
brain | 29% | 582.77 | 776 / 2642 | 99% | 49.95 | 695 / 705 |
esophagus | 52% | 1674.81 | 748 / 1445 | 61% | 16.41 | 111 / 183 |
bladder | 52% | 2017.86 | 11 / 21 | 48% | 10.18 | 240 / 504 |
blood vessel | 100% | 12379.47 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 6133.06 | 793 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 13311.73 | 1179 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 40.46 | 39 / 45 |
pancreas | 2% | 46.69 | 7 / 328 | 83% | 24.22 | 148 / 178 |
heart | 83% | 2996.21 | 718 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 13.56 | 22 / 29 |
stomach | 13% | 338.99 | 46 / 359 | 55% | 10.92 | 156 / 286 |
intestine | 22% | 532.17 | 213 / 966 | 44% | 8.65 | 234 / 527 |
adrenal gland | 26% | 575.38 | 68 / 258 | 22% | 4.99 | 51 / 230 |
kidney | 7% | 147.83 | 6 / 89 | 22% | 3.45 | 198 / 901 |
liver | 0% | 0 | 0 / 226 | 7% | 1.14 | 29 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 0.28 | 2 / 80 |
peripheral blood | 1% | 51.70 | 12 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0048844 | Biological process | artery morphogenesis |
GO_0007224 | Biological process | smoothened signaling pathway |
GO_0097150 | Biological process | neuronal stem cell population maintenance |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000648 | Biological process | positive regulation of stem cell proliferation |
GO_0072089 | Biological process | stem cell proliferation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045880 | Biological process | positive regulation of smoothened signaling pathway |
GO_0002053 | Biological process | positive regulation of mesenchymal cell proliferation |
GO_0060021 | Biological process | roof of mouth development |
GO_0048664 | Biological process | neuron fate determination |
GO_0030326 | Biological process | embryonic limb morphogenesis |
GO_0010463 | Biological process | mesenchymal cell proliferation |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0048701 | Biological process | embryonic cranial skeleton morphogenesis |
GO_0070570 | Biological process | regulation of neuron projection regeneration |
GO_0042474 | Biological process | middle ear morphogenesis |
GO_0051216 | Biological process | cartilage development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0071837 | Molecular function | HMG box domain binding |
Gene name | PRRX1 |
Protein name | Paired related homeobox 1 Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1) (PRX-1) |
Synonyms | PMX1 |
Description | FUNCTION: Master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. Orchestrates the functional drift of fibroblasts into myofibroblastic phenotype via TGF-beta signaling by remodeling a super-enhancer landscape. Through this function, plays an essential role in wound healing process . Acts as a transcriptional regulator of muscle creatine kinase (MCK) and so has a role in the establishment of diverse mesodermal muscle types. The protein binds to an A/T-rich element in the muscle creatine enhancer (By similarity). May play a role in homeostasis and regeneration of bone, white adipose tissue and derm (By similarity). .; FUNCTION: [Isoform 1]: Transcriptional activator, when transfected in fibroblastic or myoblastic cell lines. This activity may be masked by the C-terminal OAR domain. .; FUNCTION: [Isoform 2]: Transcriptional repressor, when transfected in fibroblastic or myoblastic cell lines. . |
Accessions | G3V2N3 P54821 ENST00000367760.7 [P54821-2] ENST00000497230.2 ENST00000239461.11 [P54821-1] |